Kynamro
- Product NDC
- 70688-0502
- 11-digit product format
- 706880502
- Labeler code
- 70688
- Product ID
- 70688-0502_900bb03a-deb5-4522-8dc1-755994b073b6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- MIPOMERSEN SODIUM
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Kastle Therapeutics, LLC
- Application
- NDA203568
- Marketing category
- NDA
- Marketing start
- 2016-05-02
- Marketing end
- 0000-00-00
- Substance
- MIPOMERSEN SODIUM
- Active strength
- 200 mg/mL
- Pharmacologic classes
- Apolipoprotein B-100 Synthesis Inhibitor [EPC],Decreased Protein Synthesis [PE],Antisense Oligonucleotide [EPC],Oligonucleotides, Antisense [CS]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70688-0502-1 | Kynamro | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 2 |
| 70688-0502-1 | Kynamro | 1 mL in 1 SYRINGE | INJECTION, SOLUTION | 1 | | 2 |
| 70688-0502-2 | Kynamro | 1 mL in 1 SYRINGE | INJECTION, SOLUTION | 1 | | 2 |
| 70688-0502-2 | Kynamro | 4 in 1 CARTON | INJECTION, SOLUTION | 4 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70688-0502 | KYNAMRO (MIPOMERSEN SODIUM) INJECTION, SOLUTION [KASTLE THERAPEUTICS, LLC] | 2 | Legacy NDC, 4 package rows | 20170217_774c7847-490b-41d5-9e0e-2baedbc94f62.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Status |
|---|
| 70688-0502-1 | 70688050201 | 1 in 1 CARTON | | Historical |
| 70688-0502-2 | 70688050202 | 1 mL in 1 SYRINGE | 1 ml | Historical |